Structure (9d7a71ba 8f63 48ea 90e3 9152a52a67e6 01)
Carmustine Kit
Product Images NDC 23155-790
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Carmustine (NDC 23155-790). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (9d7a71ba 8f63 48ea 90e3 9152a52a67e6 02)
Diluent Label (9d7a71ba 8f63 48ea 90e3 9152a52a67e6 03)
This is the package insert for a vial of dehydrated alcohol injection, USP, which is a sterile diluent for carmustine for injection, USP. It is advised to store the vial in a refrigerator between 2°C-8°C. The manufacturer is Gland Pharma Ltd. located in Visakhapatnam, Andhra Pradesh, India and the product has a Nog number of 2315578931. The package has a Novaplus code of k-1 and a 01 code of 00323155789317. This product is specifically for R use only. It was manufactured for and distributed by Avet Pharmaceuticals Inc. business located in East Brunswick, NJ. This product has a manufacturing license number of 03/VP/AP/2011/F/R and a revision date of 11/2020. The text "Non Varnished 18x8mm" does not provide any relevant information.*
Vial Label (9d7a71ba 8f63 48ea 90e3 9152a52a67e6 04)
Carmustine for Injection is a prescribed medication for intravenous infusion. The 100mg single-dose vial must be refrigerated immediately after reconstitution. The reconstituted solution is stable for 24 hours. Wearing gloves is recommended while handling this medication. It is not returnable. The usual dosage should be read through the enclosed package insert. After examining the solution, crystals should be dissolved by warming the vial at room temperature. The remaining unused portion must be discarded. However, the output seems to have some missing and unreadable characters.*
Carton (9d7a71ba 8f63 48ea 90e3 9152a52a67e6 05)
The text describes a medication called Carmustine for Injection, which is administered through intravenous infusion after reconstitution. Each carton includes 1 vial of Carmustine for injection (100 ml) and 1 vial of sterile diluent for reconstitution. The medication must be refrigerated immediately and unused portions should be discarded. The usual dosage and usage instructions are provided in the enclosed package insert. The medication is manufactured by Gland Pharma Limited in India for et Pharmaceuticals Inc. Gloves should be worn when handling containers, and the medication should be protected from light.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
